Belusha

Belusha is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is used for birth control and may also help manage acne. This medication is manufactured by Gedeon Richter Plc. and is suitable for oral use.

Belusha is primarily used as a contraceptive to prevent pregnancy. It works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg. Additionally, it may be prescribed to treat acne in women who also require contraception. The active ingredients, drospirenone and ethinylestradiol, contribute to its effectiveness in these areas.

Common effects of Belusha may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users might experience nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Belusha should be used with caution in individuals with a history of blood clots, liver disease, or high blood pressure. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be advised to ensure safety during use.

Belusha may interact with certain medications, including those that induce or inhibit liver enzymes, such as some antibiotics and anticonvulsants. It is advisable to inform a healthcare provider about all current medications to avoid potential interactions. Alcohol consumption should also be moderated while using this contraceptive.